Cat No.
CEI-0698
Description
BIBF1120 is a triple angiokinase inhibitor. It blocks signaling through vascular endothelial growth factor receptors (VEGFR; IC50 values of 13 to 34 nM), platelet-derived growth factor receptors (PDGFR; IC50 values of 59 to 65 nM), and fibroblast growth factor receptors (FGFR; IC50 values of 37 to 610 nM).
CAS No.
928326-83-4
Product_Overview
A triple angiokinase inhibitor
Targets
KDR, PDGFRB
Chemical Name
(Z)-?methyl 3-?(((4-?(N-?methyl-?2-?(4-?methylpiperazin-?1-? yl)acetamido)phenyl)amino)(phenyl)methylene)-?2-?oxoindoline-?6-? carboxylate
M.Wt
277.71
Purity
>96% by TLC and LC-MS
Appearance
Yellow solid
Solubility
DMSO
Storage
-20 centigrade
Shipping Conditions
Gel pack
Handling
Protect from light and moisture
Usage
For Research Use Only! Not For Use in Humans.
